| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2073 |
| Trial ID | NCT03879382 |
| Disease | Pomes Syndrome | Proteus Syndrome |
| Altered gene | CD19|BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BCMA/CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES |
| Year | 2019 |
| Country | China |
| Company sponsor | Hrain Biotechnology Co., Ltd. |
| Other ID(s) | HRain-POMES01 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||